" class="no-js "lang="en-US"> NHSX Archives - Medtech Alert
Thursday, May 23, 2024

Sort by:

Date

Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

NHS Offers Home Blood Pressure Checks to Save Thousands of Lives

Hundreds of thousands of people will be able to test their blood pressure at home, […]

Musculoskeletal (MSK) Funding Opens

Funding has been created to support Integrated Care Systems (ICSs) who have an active interest […]

my mhealth and University of Southampton announced as Round 2 Winner of The Artificial Intelligence in Health and Care Award

my mhealth Limited and the University of Southampton have been announced as a winner of […]

Qure.ai ’s Brain CT AI Wins Funding from the NHS

The UK Department of Health and Social Care announced that Qure.ai has been selected as […]

Portable ECG Device to be Further Rolled Out After Successful Pilot

A portable ECG monitoring device that detects heart irregularities is to be rolled out across […]

Vaccine Status Drives Over One Million New Users to the NHS App

Over 1.3 million new people have registered to use the NHS App since the addition […]

Ambulance iPads Improve Patient Care Under NHS Long Term Plan

Tens of thousands of iPads will be issued to ambulance crews across England so that […]

NHSX: AI at the Forefront of Efforts to Treat Coronavirus Patients

NHSX, a unit tasked with driving the digital transformation of care in the NHS, has […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more